Dermedic Jacek Zdybski

At Dermedic Jacek Zdybski in Kielce, clinical research focuses on Dermatology with a strong emphasis on immune system diseases and skin and connective tissue diseases. The studies are centered on understanding and improving care for chronic inflammatory and autoimmune skin conditions, with the goal of testing new treatment options and assessing how well they reduce disease activity.

• Subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus are being studied to evaluate whether new therapies can better control skin involvement and improve disease burden.
• Atopic dermatitis research is aimed at finding more effective ways to relieve inflammation, itching, and persistent eczema symptoms.
• Hidradenitis suppurativa trials are assessing potential treatments for a painful, hard-to-manage inflammatory skin condition.

Overall, the site is contributing to clinical trials that explore better treatment effectiveness for long-term skin disorders, especially conditions driven by immune dysregulation and chronic inflammation.

This research area at the Dermatology department includes studies in autoimmune skin disease and pigment-related conditions. The trials are designed to test whether investigational therapies can improve visible skin changes, reduce symptoms, and offer more reliable disease control for patients with difficult-to-treat disorders.

• Non-segmental vitiligo studies are evaluating new approaches to support repigmentation and improve treatment response.
• Alopecia areata trials are focused on whether emerging therapies can help restore hair growth in severe cases.
• Cutaneous lupus erythematosus research is examining options for patients who have not responded well to standard antimalarial therapy.

These projects reflect a broader effort to advance diagnostics and therapeutic effectiveness in chronic immune-related skin conditions, while addressing unmet needs for patients in Poland and across Europe.

Clinical trials at this site also address common but burdensome inflammatory disorders, especially atopic dermatitis and related eczema presentations. The research aims to determine whether new medicines can improve symptom control, reduce flare severity, and offer better day-to-day quality of life for people living with persistent skin inflammation.

• Atopic dermatitis studies are evaluating treatment effectiveness in adults with moderate to severe disease.
• Eczema research is exploring options that may better relieve itching, redness, and irritation.
• Skin disease activity measures are being used to understand how well investigational therapies reduce visible signs of inflammation.

By concentrating on long-standing inflammatory skin problems, the site supports research that may lead to more targeted and practical treatment choices for patients and clinicians alike.